Literature DB >> 8676479

Inducible human immunodeficiency virus type 1 packaging cell lines.

H Yu1, A B Rabson, M Kaul, Y Ron, J P Dougherty.   

Abstract

Packaging cell lines are important tools for transferring genes into eukaryotic cells. Human immunodeficiency virus type 1 (HIV-1)-based packaging cell lines are difficult to obtain, in part owing to the problem that some HIV-1 proteins are cytotoxic in a variety of cells. To overcome this, we have developed an HIV-1-based packaging cell line which has an inducible expression system. The tetracycline-inducible expression system was utilized to control the expression of the Rev regulatory protein, which in turn controls the expression of the late proteins including Gag, Pol, and Env. Western blotting (immunoblotting) demonstrated that the expression of p24gag and gp120env from the packaging cells peaked on days 6 and 7 postinduction. Reverse transcriptase activity could be detected by day 4 after induction and also peaked on days 6 and 7. Defective vector virus could be propagated, yielding titers as high as 7 x 10(3) CFU/ml, while replication-competent virus was not detectable at any time. Thus, the cell line should enable the transfer of specific genes into CD4+ cells and should be a useful tool for studying the biology of HIV-1. We have also established an inducible HIV-1 Env-expressing cell line which could be used to propagate HIV-1 vectors that require only Env in trans. The env-minus vector virus titer produced from the Env-expressing cells reached 2 x 10(4) CFU/ml. The inducible HIV-1 Env-expressing cell line should be a useful tool for the study of HIV-1 Env as well.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676479      PMCID: PMC190389     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Construction and use of a safe and efficient amphotropic packaging cell line.

Authors:  D Markowitz; S Goff; A Bank
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

2.  HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.

Authors:  M Goodenow; T Huet; W Saurin; S Kwok; J Sninsky; S Wain-Hobson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

3.  5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal.

Authors:  R D Berkowitz; M L Hammarskjöld; C Helga-Maria; D Rekosh; S P Goff
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

Review 4.  Viral latency in HIV disease.

Authors:  J M McCune
Journal:  Cell       Date:  1995-07-28       Impact factor: 41.582

5.  Improved retroviral packaging lines derived from spleen necrosis virus.

Authors:  I Martinez; R Dornburg
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

6.  Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.

Authors:  C Aiken; D Trono
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

7.  Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.

Authors:  R C Mulligan; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.

Authors:  J P Dougherty; R Wisniewski; S L Yang; B W Rhode; H M Temin
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

9.  Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr.

Authors:  V Planelles; F Bachelerie; J B Jowett; A Haislip; Y Xie; P Banooni; T Masuda; I S Chen
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.

Authors:  S Parthasarathi; A Varela-Echavarría; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  17 in total

1.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

Authors:  Anna Stornaiuolo; Bianca Maria Piovani; Sergio Bossi; Eleonora Zucchelli; Stefano Corna; Francesca Salvatori; Fulvio Mavilio; Claudio Bordignon; Gian Paolo Rizzardi; Chiara Bovolenta
Journal:  Hum Gene Ther Methods       Date:  2013-08-03       Impact factor: 2.396

3.  A packaging cell line for lentivirus vectors.

Authors:  T Kafri; H van Praag; L Ouyang; F H Gage; I M Verma
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

4.  Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.

Authors:  V N Kim; K Mitrophanous; S M Kingsman; A J Kingsman
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

5.  High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Authors:  A E Jetzt; H Yu; G J Klarmann; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector.

Authors:  G Sun; P K O'Neil; H Yu; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  Engraftment of NOD/SCID mice with human CD34(+) cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein.

Authors:  J Gatlin; M W Melkus; A Padgett; P F Kelly; J V Garcia
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

Authors:  Jianling Zhuang; Amanda E Jetzt; Guoli Sun; Hong Yu; George Klarmann; Yacov Ron; Bradley D Preston; Joseph P Dougherty
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.

Authors:  F Mammano; F Salvatori; S Indraccolo; A De Rossi; L Chieco-Bianchi; H G Göttlinger
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

10.  GPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.

Authors:  Michael Wen; Reetakshi Arora; Huiqiang Wang; Lihong Liu; Jason T Kimata; Paul Zhou
Journal:  Retrovirology       Date:  2010-10-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.